Back Login to subscribe 🔔 Set Alert

LLY Eli Lilly & Co.

Sector: Healthcare
Industry: Drug Manufacturers - General
15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
LLY Fundamental Data
Loading...
Similar Companies
Loading...
LLY Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
LLY Insider Transactions
Loading insider data…
LLY News
Date Headline Sentiment
Eli Lilly Announces Detailed Results From The Phase 3 ACHIEVE-4 Trial Evaluating The Efficacy And Safety Of Foundayo; Foundayo Experienced A 16% Lower Risk Of MACE-4 And A 23% Lower Risk Of MACE-3, Meeting The Primary Objective For Non-inferiority Compared To Insulin Glargine
46.44%
Eli Lilly Data Shows Retatrutide Promotes Weight Loss Over Eighty Weeks
83.12%
10 Health Care Stocks With Whale Alerts In Today’s Session
90.45%
Tirzepatide or Semaglutide? Novo Nordisk Says Higher Semaglutide Dose Shows Cardiovascular Edge Over Eli Lilly's Tirzepatide (CORRECTED)
76.05%
Eli Lilly Says EloraTZP Cut Weight Up To 23.3% Vs. 14.8% For Tirzepatide In Phase 2b Diabetes Trial; Plans Phase 3 In Q4
93.57%
Lilly's EBGLYSS Monotherapy Met Primary And Secondary Endpoints At Week 16 In Its Phase 3B ADtouch Study, Showing Significant And Rapid Improvements In Hand And Foot Skin Clearance, Itch And Pain In Adults And Adolescents With Moderate-To-Severe Hand And Foot Atopic Dermatitis
57.37%
Bill Clinton Sounds Alarm on HIV Funding: ‘Cheaper Medicines Mean Nothing If They Never Reach People’
68.96%
Eli Lilly Announces Detailed Results From TRIUMPH-2; TRIUMPH-2 Participants With Obesity And Type 2 Diabetes Taking Retatrutide 12 Mg Lost An Average Of 49.6 Lbs Over 80 Weeks; Retatrutide 12 Mg Leads To 60.8 Lb Weight Loss In BMI ≥35 Group; To Submit Biologics License Application For Retatrutide In Q1 2027
79.24%
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You
93.19%
Weight Watchers Expands GLP-1 Era Strategy With Google Health
74.36%